Determination of gelatinase-A (MMP-2) activity using a novel immunocapture assay.
Nycomed Amersham, Cardiff Laboratories, Whitchurch, Cardiff, Wales, UK. stephen.capper@eu.apbiotech.com
S J
SJ
Capper
J
J
Verheijen
L
L
Smith
M
M
Sully
H
H
Visser
R
R
Hanemaaijer
D000595:Amino Acid Sequence; D000918:Antibody Specificity; D001665:Binding Sites; D001943:Breast Neoplasms / Q000201:enzymology; D003124:Colorimetry / Q000379:methods; D003429:Cross Reactions; D004792:Enzyme Precursors / Q000032:analysis; D004800:Enzymes, Immobilized / Q000378:metabolism; D005260:Female; D018093:Gelatinases / Q000032:analysis* / Q000097:blood / Q000652:urine; D006801:Humans; D007118:Immunoassay / Q000379:methods; D020778:Matrix Metalloproteinase 2; D008666:Metalloendopeptidases / Q000032:analysis* / Q000097:blood / Q000652:urine; D016297:Mutagenesis, Site-Directed; D011994:Recombinant Proteins / Q000378:metabolism; D012463:Saliva / Q000201:enzymology
D004792:Enzyme Precursors; D004800:Enzymes, Immobilized; D011994:Recombinant Proteins; D018093:Gelatinases; D008666:Metalloendopeptidases; C069860:progelatinase; D020778:Matrix Metalloproteinase 2